The drug, is used for hyperactivity control. Of course all these legal cases add to the cost of what we pay for drugs too. There’s a coupon offer on the Intuniv website as well which I am guessing is to also help retain business.
In a related story, Teva gets a warning from the FDA relative to the manufacturing facility in Irvine, California. Here’s one more example of Pfizer taking Teva to court and Teva has their own set of court cases they have initiated as well relative to challenging patents. BD
Pfizer Suing Teva To Block Generic Version of Viagra Until 2019 Instead of 2012 Expiration Date – Viva Teva
LONDON -(Dow Jones)- U.K. drug maker Shire PLC (SHP.LN) Friday said its U.S. subsidiary filed a lawsuit there against Teva Pharmaceutical Industries Ltd. (TEVA), alleging that the Israel-based generic drugs maker infringed two patents for Shire's hyperactivity medicine Intuniv.
Shire, the U.K.'s third-largest drug company, said its lawsuit results from an Abbreviated New Drug Application for making copycat versions of Intuniv by Teva, the world's largest generic drugs maker.
Shire's hyperactivity product, which uses the active ingredient guanfacine, only went on sale in the U.S. late last year and is protected there by three patents, which run until 2015, 2020 and 2022.